№ files_lp_3_process_9_64940
File format: docx
Character count: 2484
File size: 16 KB
This document provides guidelines for monitoring smear and culture conversion in pulmonary tuberculosis cases, outlining the required sputum sample collection schedule and conditions for assessing infectiousness and treatment progress.
Year:
2021
Region / City:
Virginia
Topic:
Tuberculosis
Document Type:
Health guidelines
Institution:
Virginia Department of Health
Author:
Not specified
Target Audience:
Healthcare professionals, TB program staff
Effective Date:
2021
Revision Date:
Not specified
Comments:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Document Type:
Laboratory Procedure
Target Organism:
Respiratory bacteria and viruses
Resistance Genes:
CTX-M, NDM, mecA/C and MREJ, IMP, OXA-48-like, KPC, VIM
Specimen Type:
Sputum-like specimens, Bronchoalveolar lavage (BAL)-like specimens
Required Equipment:
BioFire FilmArray 1.5, 2.0, or Torch System
Sample Volume:
Approximately 0.2 mL
Storage Conditions:
Refrigerated 2–8 °C for up to 1 day
Intended Users:
Clinical laboratory personnel
Procedure Duration:
Approximately 1 hour per run
Safety Precautions:
Use PPE, avoid bleach contact with specimens
Reference Materials:
FilmArray Operator’s Manual, Quick Guide, Training Video
Note:
Year
Document type:
Health guidance
Organization:
Bilbrook Medical Centre
Target audience:
Women over 50
Authors:
Yohannes Zenebe; Belay Anagaw; Wegahta Tesfaye; Tewodros Debebe; Fantahun Biadglegne; Baye Gelaw
Corresponding author:
Yohannes Zenebe ([email protected]
Note:
)
Affiliations:
Department of Microbiology, Immunology and Parasitology, College of Medicine and Health Sciences, Bahir Dar University; Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar; Department of Pathology, College of Medicine and Health Sciences, University of Gondar; Institute of Medical Microbiology and Epidemiology of Infectious Diseases, Faculty of Medicine, University of Leipzig
Study area:
Gondar, Northwest Ethiopia
Study period:
January–April 2012
Study design:
Cross-sectional study
Sample size:
344 extra pulmonary tuberculosis suspected patients
Laboratory method:
Ziehl–Neelsen staining technique for acid fast bacilli
Main outcome:
Prevalence of smear positive extra pulmonary tuberculosis (9.9%)
Key associated factors:
Previous history of tuberculosis; contact with known tuberculosis cases; underlying diseases; income level
Thematic area:
Tuberculosis; Extra pulmonary tuberculosis; HIV co-infection; Public health
Type of document:
Scientific research article
Geographical focus:
Northwest Ethiopia
Statistical analysis:
Bivariate and multivariate logistic regression
Keywords:
Extra pulmonary tuberculosis; Northwest Ethiopia
Year:
2021
Region / City:
Bethesda, MD, USA
Topic:
Malaria, Medical Imaging
Document Type:
Dataset
Organization:
National Library of Medicine, National Institutes of Health
Author:
Yasmin M Kassim, Feng Yang, Hang Yu, Richard J Maude, Stefan Jaeger
Target Audience:
Researchers in medical imaging and parasitology
Data Format:
JPEG images with TXT annotation files
Number of Subjects:
150 patients
Images per Subject:
~20
Annotation Details:
Parasite positions and types, circle coordinates
License:
Creative Commons Attribution
Date of Compilation:
06/03/2021
Year:
2024
Regulatory authority:
Therapeutic Goods Administration (TGA)
Medicine:
MACITENTAN 10 mg with TADALAFIL 40 mg (Opsynvi®)
Indication:
Pulmonary arterial hypertension (PAH), WHO Group 1, functional class II and III
Therapy type:
Dual or triple combination therapy
Dosage form:
Tablet, fixed dose combination (FDC)
Prescriber type:
Medical practitioners
Restriction type:
Authority Required (Written, Complex Authority Required)
Clinical criteria:
Treatment as dual therapy (MAC+TAD) or triple therapy with prostanoid
Population:
Adult patients with stable PAH on separate doses of macitentan and tadalafil
Previous considerations:
PBAC recommendations for macitentan and tadalafil since 2011–2014
Approval date:
16 September 2024
Source documents:
TGA registration, PBAC meeting minutes, ACM minutes August 2024, FDA, EMA, CDA references
Year:
2023
Region / City:
Japan
Topic:
Pulmonary disease, stem cells, regenerative medicine
Document Type:
Research article
Organization / Institution:
Nagasaki University, Tokyo University
Author:
Mayumi Iwatake, Tokiko Nagamura-Inoue, Ryoichiro Doi, Yukinori Tanoue, Mitsutoshi Ishii, Hiroshi Yukawa, Tomoshi Tsuchiya
Target Audience:
Researchers, clinicians in regenerative medicine
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Cell culture:
Human umbilical cord mesenchymal stem cells (UC-MSCs)
Animal model:
C57BL/6 mice
Ethical compliance:
Nagasaki University Institutional Animal Care and Use Committee
Note:
Approval No. 1807101460-2
Year:
2013
Region / city:
Not specified
Subject:
CT Pulmonary Angiograms, Contrast Enhancement
Document Type:
Medical Protocol
Institution:
Not specified
Author:
Dr. Michelle Muller, Dr. Anna Beattie, A. Chang, J. May
Target Audience:
Radiologists, Radiographers, Medical Professionals
Period of Validity:
Ongoing
Approval Date:
5 January 2013
Last Reviewed:
20 July 2022
Changes Date:
2022
Suggested Changes:
Ensure proper contrast injection and scanning protocols
Contextual Description:
Medical protocol for ensuring adequate contrast enhancement in CT pulmonary angiograms for diagnostic purposes.
Year:
2023
Region / City:
United States
Topic:
Infectious diseases, prevention, and treatment
Document type:
Health advisory
Organization / Institution:
Centers for Disease Control and Prevention (CDC)
Author:
Centers for Disease Control and Prevention (CDC)
Target audience:
General public
Date of approval:
Not specified
Date of changes:
Not specified
Year:
2024
Region / City:
Morgantown, West Virginia
Topic:
Occupational Safety and Health, Spirometry Training
Document Type:
Federal Regulation and Approval Request
Institution:
National Institute for Occupational Safety and Health
Author:
Kathleen Rogers, BS, RRT, CPFT
Target Audience:
Sponsors and applicants for NIOSH-approved spirometry training courses
Validity Period:
5 years (for course renewal)
Approval Date:
January 2, 2024
Date of Revisions:
None indicated
Version:
1
Date:
April 2023
Study name:
TDA4Child study
Full title:
Evaluating the performance, feasibility, acceptability and impact of treatment-decision algorithms for pulmonary tuberculosis in children
Health condition:
Pulmonary tuberculosis in children
Intervention:
Treatment-decision algorithms for childhood tuberculosis
Study type:
Clinical research protocol
Study design:
Multisite evaluation study
Target population:
Children with presumptive pulmonary tuberculosis
Geographical scope:
Country-specific implementation
Guideline basis:
WHO consolidated guidelines on the management of tuberculosis in children and adolescents (2022)
Responsible organization:
World Health Organization
Leading programme:
Special Programme for Research and Training in Tropical Diseases (TDR)
Funding organizations:
WHO Global Tuberculosis Programme; UNOPS; United States Centers for Disease Control and Prevention
Ethical considerations included:
Ethical approval, informed consent, assent
Outcome measures:
Primary and secondary outcomes related to diagnostic and treatment decisions
Data components:
Data collection, management and statistical analysis plan
Period covered:
Study period as defined in the protocol
Year:
2023
Region / City:
England
Topic:
Healthcare, Quality Standards
Document Type:
Policy document
Organization / Institution:
NHS England
Author:
General Practice Specification and Extraction Service (GPSES), NHS England
Target Audience:
Healthcare providers, Medical professionals
Period of Validity:
2023-2024
Approval Date:
01/04/2023
Date of Amendments:
01/08/2023
Contextual Description:
Policy document outlining business rules for COPD management under the Quality and Outcomes Framework for NHS England.
Published date:
Saturday 14 September 2013
Last reviewed:
Thursday 28 July 2022
Type of document:
Clinical audit protocol
Clinical domain:
Thoracic radiology
Subject:
Follow-up of indeterminate pulmonary nodules on CT
Guidelines referenced:
British Thoracic Society guidelines; Fleischner Society guidelines; Royal College of Radiologists iRefer
Target population:
Adults over 18 years with pulmonary nodules detected on CXR or CT
Standard:
Follow-up of indeterminate pulmonary nodules in accordance with BTS and RCR guidelines
Audit targets:
95% compliance in reporting recommendations and follow-up timing
Methodology:
Retrospective audit of CT reports and follow-up imaging using PACS/RIS
Suggested sample size:
50–75 CT examinations
Author:
Denis Remedios
Contributing sources:
Fleischner Society; British Thoracic Society; Royal College of Radiologists
Year:
2017
Note:
Region / City
Theme:
Cardiovascular and Pulmonary Health, Physical Therapy
Document Type:
Clinical Guidelines
Organization / Institution:
American College of Sports Medicine (ACSM)
Target Audience:
Healthcare professionals, physical therapists
Date of Amendments:
2017 (revised)
Year:
2023
Region / City:
Not specified
Topic:
Negative Pressure Pulmonary Oedema, General Anaesthesia, Laryngospasm
Document Type:
Case Report
Institution:
Not specified
Author:
Not specified
Target Audience:
Medical professionals, Anaesthesiologists, Pulmonologists
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2020
Region / City:
Not specified
Topic:
Pulmonary Critical Care
Document Type:
Supplemental Guide
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Medical professionals in pulmonary critical care
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
Not specified
Subject:
Pulmonary edema, ultrasound, radiofrequency signal
Document type:
Research study
Organization / Institution:
Not specified
Authors:
Hyuksool Kwon, MD, PhD; You Hwan Jo, MD, PhD; Jae Hyuk Lee, MD, PhD; Ji Eun Hwang, MD; Inwon Park, MD, PhD; Seonghye Kim; Dong-Hyun Jang, MD; Do Yun Kim, MD; Hyunglan Chang, MD
Target audience:
Medical professionals, researchers
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2017
Region / city:
Khartoum, Sudan
Topic:
Pulmonary Artery Pressure, Echocardiography, Pulmonary Hypertension
Document Type:
Research Study
Organization / Institution:
Sudan University of Science and Technology, Batterjee Medical College, National Ribat University, University of Jeddah, Al-Ghad International College for Applied Medical Science
Authors:
Emad Eldein Dahab, Mohamed Yousef, Mohammed Gar-alnabi, Hanady Elyas Osman, Awadalla Wagealla, Lubna Bushara, Ikhlas Abdalaziz, Huda Osama
Target Audience:
Medical professionals, researchers, students in medical and radiological sciences
Study Period:
June 2015 to June 2017
Approval Date:
N/A
Date of Revisions:
N/A
Keywords:
Pulmonary Artery Pressure, Echocardiogram, Healthy People, Right Ventricle, Pulmonary Artery Systolic Pressure
Context:
Research paper that estimates the standard value of pulmonary artery pressure in a healthy Sudanese population using echocardiogram.
Year:
Not specified
Region / City:
Indiana
Subject:
Cardiovascular and Pulmonary Rehabilitation
Document Type:
Constitution
Organization:
Indiana Society of Cardiovascular and Pulmonary Rehabilitation
Author:
Not specified
Target Audience:
Health care professionals, members of the Society
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified